Crossmark

Clinical efficacy and safety of anti-VEGF biosimilars compared to reference anti-VEGF agents for neovascular age-related macular degeneration: a systematic review, meta-analysis, and meta-regression

Crossref DOI link: https://doi.org/10.1007/s10792-026-04043-5

Published Online: 2026-03-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Shammari, Yousef Mesaed

AlDhafiri, Yousef M.

Ahmad, Abdullah Kamal

Alkharraz, Basel Bader

Al-Awadhi, Mohammed Ahmad

Alnabhan, Rashed Mesaed
License Information

Text and Data Mining valid from 2026-03-20

Version of Record valid from 2026-03-20
More Information

Article History

Received: 21 October 2025

Accepted: 10 March 2026

First Online: 20 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below